Rx Medicare

The Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of a conditional marketing authorisation for a fourth pandemic vaccine, Arepanrix from GlaxoSmithKline Biologicals. This recommendation was made using an emergency procedure which fast-tracks evaluation of new vaccines developed during a pandemic…

Read More…

Related Posts

• European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
• European Medicines Agency Reaffirms Efficacy And Safety Of H1N1v Pandemic Vaccines
• Baxter Receives European Commission Approval For CELVAPAN H1N1 Pandemic Influenza Vaccine
• A(H1N1) Influenza Pandemic: Sanofi Pasteur’s Global Response
• Statement By The Welsh Assembly Government On Latest Developments In Respect Of The Influenza A (H1N1) Swine Flu Pandemic
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children
• Practice Fusion Identifies 300,000 High-Risk Patients For H1N1 Influenza Vaccine, In-line With CDC Pandemic Guidelines
• USDA Conducting Confirmatory Testing On Possible Detection Of 2009 Pandemic H1N1 Influenza In U.S. Swine
• Healthcare Distributors Stand Ready To Work With State Governments To Take On Influenza Pandemic Challenge
• Baxter Receives EMEA Positive Opinion For CELVAPAN H1N1 Pandemic Influenza Vaccine
• New Articles To Protect Vulnerable Populations During An Influenza Pandemic Published In Special Issue Of American Journal Of Public Health
• Influenza pandemic: your best defence is you.
• Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses In Animal Studies
• Changes To HPA Pandemic Flu Media Updates, UK
• European Medicines Agency Recommends Withdrawal Of Dextropropoxyphene-containing Medicines

Tags: agency, efficacy, european, influenza, medicines, pandemic, updates

This entry was posted on Monday, January 25th, 2010 at 2:01 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.